Pneumocystis carinii pneumonia during maintenance anti-tumor necrosis factor-alpha therapy with infliximab for Crohn's disease. [electronic resource]
Producer: 20041116Description: 657-60 p. digitalISSN:- 1078-0998
- Adult
- Antibodies, Monoclonal -- adverse effects
- Azathioprine -- adverse effects
- Crohn Disease -- drug therapy
- Gastrointestinal Agents -- adverse effects
- Humans
- Immunosuppressive Agents -- adverse effects
- Infliximab
- Male
- Pneumonia, Pneumocystis -- chemically induced
- Treatment Outcome
- Tumor Necrosis Factor-alpha
No physical items for this record
Publication Type: Case Reports; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.